Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid-Associated Osteopenia and Osteoporosis

NCT00209469 is registered in ClinicalTrials.gov with Glaser Pediatric Research Network as lead sponsor.

NCT NCT00209469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid-Associated Osteopenia and Osteoporosis
Lead sponsor
Glaser Pediatric Research Network
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2002
Completion date
February 28, 2007
Enrollment
90
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, osteoporosis